OUR TEAM

Andrew Wasson

Partner

Andrew Wasson

Partner

Having grown up with a father who is a patent lawyer, Mr. Wasson has been involved in patents in one way or another for the better part of his life
Having grown up with a father who is a patent lawyer, Mr. Wasson has been involved in patents in one way or another for the better part of his life

OVERVIEW

Andrew Wasson is a partner and Chair of Haug Partners’ FDA practice in the New York office. Andrew has a broad range of experience in both the brand and generic side of pharmaceuticals, especially with respect to issues involving intellectual property law and regulatory law. Having grown up with a father who is a patent lawyer, Mr. Wasson has been involved in patents in one way or another for the better part of his life and has the advantage of being able to deal with complex patent law concepts in a very natural way. Mr. Wasson is registered to practice before the U.S. Patent and Trademark Office and has published extensively in both scientific and legal literature. Mr. Wasson serves as an Adjunct Lecturer of Entrepreneurship & Innovation at the Hynes Institute for Entrepreneurship & Innovation at Iona College.

PUBLICATIONS

VIEW ALL

SPEAKING ENGAGEMENTS

  • The CREATES Act Has Passed: What Does It Mean for the Generics Industry?, FDLI Webinar (Jan. 22, 2020)
  • IP Due Diligence Considerations for the Life Science Industry: What You Should Know, Knowledge Group Webinar (Dec. 6, 2019)
  • Patents and Related Protections and Mechanisms, ACI’s FDA Bootcamp, Boston MA (Sept. 18, 2019).
  • Innovative Medical Product Technologies, Novel Products, and FDA Regulation, Food and Drug Law Institute Annual Conference, Washington DC (May 2, 2019).
  • Workshop on Concepts in Intellectual Property Law, Hynes Institute for Entrepreneurship & Innovation, Iona College, New Rochelle NY (Feb. 22, 2019).
  • “Addressing Risk and Opportunities in Life Sciences IP Due Diligence”, Knowledge Group Webinar (November 14, 2018)
  • “Keynote: The Regulatory Perspective: The Next Horizon of Innovation”, Moderator, BioNJ’s C-Suite Summit 2018 Take It To the Top, Bridgewater, NJ (October 25, 2018)
  • “REMS Restrictions and Generic Entry: Trends and Developments in Legislative and Regulatory Activity,” 10th Risk Evaluation & Mitigation Strategies Summit, Crystal City VA (Jan. 30, 2018)
  • Workshop on Concepts in Intellectual Property Law, Hynes Institute for Entrepreneurship & Innovation, Iona College, New Rochelle NY (Feb. 19, 2018).
  • “The BPCIA Patent Dance: What’s Old and What’s New in 2018”, Knowledge Group Webinar (June 28, 2018)
  • “The BPCIA Patent Dance: Recent Trends, Developments and Court Decisions,” The Knowledge Group, Webinar (August 9, 2017)
  • “Lessons Learned: Disputes & IP”, Fourth Due Diligence Summit for Life Sciences, Boston, MA (May 19, 2017)
  • “Inter Partes Review in Pharmaceuticals and Biotech”, Lawline, New York, NY (Feb. 24, 2017)
  • “Recent Developments on IP and REMS”, 9th Risk Evaluation & Mitigation Strategies Summit, Arlington, VA (Jan. 27, 2017)
  • “Aligning IP Protection and Regulatory Compliance with the Product Development Cycle”, Medical Devices Summit 2016, Boston MA (Feb. 10, 2016).
  • “Fundamentals of FDA Regulatory Law”, American Conference Institute, FDA Boot Camp, Boston MA (Sept. 29, 2015).
  • “Third Party IP: Preserving Freedom to Operate, Food and Drug Law Institute”, Intellectual Property Throughout the Drug Development Lifecycle, Washington D.C. (July 7, 2012).
  • “First-filed Generic Exclusivity and Forfeiture Thereof”, New Jersey Intellectual Property Law Association, 25th Annual Pharmaceutical / Chemical Patent Practice Update, New Brunswick, NJ (Dec. 7, 2011).
VIEW ALL

AWARDS

  • SuperLawyers® Metro Edition, 2013-2017 Rising Stars

EDUCATION

  • Haverford College, (B.A., Biology, 2002)
  • Duke University School of Law, (J.D./M.A., 2005)

BAR ADMISSIONS

  • New York
  • Registered to practice before the U.S. Patent and Trademark Office

MEMBERSHIPS

  • New York Intellectual Property Law Association
  • American Chemical Society

RELATED SERVICES

Appellate Litigation

Biotechnology Litigation

Class Action Litigation

Due Diligence & Investigations

FDA

Hatch-Waxman Litigation

Intellectual Property Litigation

Life Sciences Litigation

Patent Prosecution

PTAB Post-Issuance Proceedings

VIEW ALL
Haug Partners

CONTACT

LOCATION

New York City
745 Fifth Avenue, 10th Floor, New York, NY 10151
+1.212.588.0800
745 Fifth Avenue, 10th Floor, New York, NY 10151
VIEW IN MAPS
Haug Partners

Locations

New York, NY

745 Fifth Avenue
10th Floor
New York, NY 10151

+1.212.588.0800

West Palm Beach, FL

777 South Flagler Drive
Phillips Point East Tower, Suite 1000
West Palm Beach, FL 33401

+1.561.489.4600

Contact

Follow us

Linkedin Twitter
©2021 Haug Partners
Haug Partners